Brainstorm Cell Therapeutics Inc.

What is Brainstorm Cell Therapeutics Inc. (BCLI) stock price today?

As of Dec 15, 2025, 6:52 PM UTC, Brainstorm Cell Therapeutics Inc. (BCLI) stock is trading at $0.56. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date BCLI stock quotes for informed trading decisions.

What is Brainstorm Cell Therapeutics Inc.'s market capitalization?

Brainstorm Cell Therapeutics Inc. (BCLI) has a market capitalization of approximately $6.2M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Brainstorm Cell Therapeutics Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the BCLI stock price changes.

What is the 52-week range for Brainstorm Cell Therapeutics Inc. stock?

Brainstorm Cell Therapeutics Inc. (BCLI) stock has traded in a 52-week range of $0.52 — $2.50. The 52-week range shows the highest and lowest prices at which BCLI traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Brainstorm Cell Therapeutics Inc. stock price to this range provides context for recent price action.

How much trading volume does Brainstorm Cell Therapeutics Inc. stock have?

Brainstorm Cell Therapeutics Inc. (BCLI) stock recently traded approximately 768 shares. Trading volume indicates market liquidity and investor interest in BCLI. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Brainstorm Cell Therapeutics Inc. stock.

Does Brainstorm Cell Therapeutics Inc. pay dividends to shareholders?

Yes, Brainstorm Cell Therapeutics Inc. (BCLI) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Brainstorm Cell Therapeutics Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Brainstorm Cell Therapeutics Inc.'s intraday price range?

Today, Brainstorm Cell Therapeutics Inc. (BCLI) stock has traded in a range of $0.56 — $0.60. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring BCLI's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Brainstorm Cell Therapeutics Inc. stock data?

AlphaPilot sources real-time BCLI stock quotes, fundamental financial data, and historical price charts for Brainstorm Cell Therapeutics Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Brainstorm Cell Therapeutics Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of BCLI stock performance.